Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 4 (2007), Issue 3 (March)

1. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
   Pediatrics, 119(3): e531-7. [Abstract] [Full-text]
2. Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry.
   Ann Hum Genet, 71: 194-201. [Abstract] [Full-text]
3. The effect of disruptions during counseling on recall of genetic risk information: the case of cystic fibrosis.
   J Genet Couns, 16(2): 179-90. [Abstract] [Full-text]
4. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
   Expert Opin Drug Deliv, 4(2): 91-4. [Abstract] [Full-text]
5. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis.
   Laryngoscope, 117(3): 475-9. [Abstract] [Full-text]
6. Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report.
   BMC Pediatr, 7: 11. [Abstract] [Full-text]
7. Clinical trials in cystic fibrosis.
   J Cyst Fibros, 6(2): 85-99. [Abstract] [Full-text]
8. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
   J Cyst Fibros, 6(2): 145-52. [Abstract] [Full-text]
9. Resting energy expenditure in cystic fibrosis as an indicator of disease severity.
   J Cyst Fibros, 6(2): 131-6. [Abstract] [Full-text]
10. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis.
    J Cyst Fibros, 6(2): 101-9. [Abstract] [Full-text]
11. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    J Cyst Fibros, 6(2): 153-8. [Abstract] [Full-text]
12. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    J Cyst Fibros, 6(2): 137-43. [Abstract] [Full-text]
13. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis.
    J Cyst Fibros, 6(2): 111-6. [Abstract] [Full-text]
14. An unusual case of abdominal pain in a patient with cystic fibrosis.
    J Cyst Fibros, 6(2): 159-60. [Abstract] [Full-text]
15. Laboratory parameter profiles among patients with cystic fibrosis.
    J Cyst Fibros, 6(2): 117-23. [Abstract] [Full-text]
16. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    J Cyst Fibros, 6(2): 125-30. [Abstract] [Full-text]
17. Cystic fibrosis: a balancing act?
    J Cyst Fibros, 6(2): 161-2. [Abstract] [Full-text]
18. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.
    Thorax, 62(4): 360-7. [Abstract] [Full-text]
19. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.
    Thorax, 62(4): 341-7. [Abstract] [Full-text]
20. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
    J Aerosol Med, 20(1): 45-9. [Abstract] [Full-text]
21. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
    J Gen Physiol, 129(4): 285-98. [Abstract] [Full-text]
22. Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene.
    Genet Test, 11(1): 32-44. [Abstract] [Full-text]
23. Testing and reporting ACMG cystic fibrosis mutation panel results.
    Genet Test, 11(1): 11-31. [Abstract] [Full-text]

© 2004-2008 Cystic Fibrosis Research Today. All Rights Reserved.